Michael F. Gutknecht

Otfried Müller Str. 10
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

T cell assays for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform.

T cell assays for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform.

Journal: Frontiers in immunology

Published: October 11, 2025

Dendritic cell maturation assay for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform.

Dendritic cell maturation assay for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform.

Journal: Frontiers in immunology

Published: September 15, 2025

MAPPs assays for non-clinical immunogenicity risk assessment: best practices recommended by the European immunogenicity platform.

MAPPs assays for non-clinical immunogenicity risk assessment: best practices recommended by the European immunogenicity platform.

Journal: Frontiers in immunology

Published: August 21, 2025

Proceedings of the 15th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals.

Proceedings of the 15th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals.

Journal: mAbs

Published: April 04, 2025

Cytomegalovirus-induced oncomodulation drives immune escape in glioblastoma.

Cytomegalovirus-induced oncomodulation drives immune escape in glioblastoma.

Journal: Scientific reports

Published: January 13, 2025

Assessing the Adjuvant Potential of Chinese Hamster Ovary Host Cell Proteins Using an In Vitro Dendritic Cell Assay.

Assessing the Adjuvant Potential of Chinese Hamster Ovary Host Cell Proteins Using an In Vitro Dendritic Cell Assay.

Journal: Biotechnology and bioengineering

Published: November 13, 2024

Host cell protein-mediated adjuvanticity and immunogenicity risks of biotherapeutics.

Host cell protein-mediated adjuvanticity and immunogenicity risks of biotherapeutics.

Journal: Biotechnology advances

Published: October 18, 2024

Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events.

Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events.

Journal: Science translational medicine

Published: February 01, 2023

nanoString evaluation of murine Cytomegalovirus transcription in vivo and in vitro.

nanoString evaluation of murine Cytomegalovirus transcription in vivo and in vitro.

Journal: Journal of virological methods

Published: October 14, 2021

Cytomegalovirus durably primes neutrophil oxidative burst.

Cytomegalovirus durably primes neutrophil oxidative burst.

Journal: Journal of leukocyte biology

Published: April 14, 2021

Characterizing treatment-related patient needs in atopic eczema: insights for personalized goal orientation.

Characterizing treatment-related patient needs in atopic eczema: insights for personalized goal orientation.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 07, 2019

Time to revise the Dermatology Life Quality Index scoring in psoriasis treatment guidelines.

Time to revise the Dermatology Life Quality Index scoring in psoriasis treatment guidelines.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: March 02, 2019

Showing 1-12 of 34

Last Updated: 09/26/2026